“Evaluation of Natural Killer Activated Receptor NKG2D, Inhibitory Receptor KIR2DL1 and Soluble Ligand MICA in Iraqi Patients of Acute Myeloid Leukemia”. Journal of Pharmaceutical Negative Results 13 (October 10, 2022): 148–155. Accessed June 4, 2026. https://pnrjournal.com/index.php/home/article/view/1761.